Incyte (INCY) Asset Utilization Ratio (2011 - 2026)
Incyte posted quarterly Asset Utilization Ratio of 0.75 for Q1 2026, down 4.89% year-on-year from 0.79 in Q1 2025, and down 3.08% on a QoQ basis from 0.77 in Q4 2025.
Incyte (INCY) has 16 years of Asset Utilization Ratio data on file, last reported at 0.75 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 4.89% year-over-year to 0.75; the trailing twelve-month figure through Mar 2026 stood at 0.75 (down 4.89% YoY), and the FY2025 full-year result was 0.83, up 19.5% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.75, down from 0.77 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.84 in Q3 2024 and bottomed at 0.54 in Q1 2024.
- The 5-year median for Asset Utilization Ratio is 0.64 (2022), against an average of 0.68.
- The widest annual swing landed in 2022, when Asset Utilization Ratio fell 16.67%; it then jumped 47.05% in 2024.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.6 in 2022, then decreased by 6.17% to 0.56 in 2023, then jumped by 44.54% to 0.81 in 2024, then dropped by 4.61% to 0.77 in 2025, then retreated by 3.08% to 0.75 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.75 (Q1 2026), 0.77 (Q4 2025), and 0.79 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.85 |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 0.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.75 |
| Dec 31, 2025 | 0.77 |
| Sep 30, 2025 | 0.79 |
| Jun 30, 2025 | 0.79 |
| Mar 31, 2025 | 0.79 |
| Dec 31, 2024 | 0.81 |
| Sep 30, 2024 | 0.84 |
| Jun 30, 2024 | 0.65 |
| Mar 31, 2024 | 0.54 |
| Dec 31, 2023 | 0.56 |
| Sep 30, 2023 | 0.57 |
| Jun 30, 2023 | 0.59 |
| Mar 31, 2023 | 0.60 |
| Dec 31, 2022 | 0.60 |
| Sep 30, 2022 | 0.62 |
| Jun 30, 2022 | 0.64 |
| Mar 31, 2022 | 0.62 |
| Dec 31, 2021 | 0.65 |
| Sep 30, 2021 | 0.72 |
| Jun 30, 2021 | 0.72 |
| Mar 31, 2021 | 0.75 |
| Dec 31, 2020 | 0.78 |
| Sep 30, 2020 | 0.75 |
| Jun 30, 2020 | 0.80 |
| Mar 31, 2020 | 0.72 |
| Dec 31, 2019 | 1.20 |
| Sep 30, 2019 | 1.35 |
| Jun 30, 2019 | 0.70 |
| Mar 31, 2019 | 0.74 |
| Dec 31, 2018 | 0.73 |
| Sep 30, 2018 | 0.73 |
| Jun 30, 2018 | 0.74 |
| Mar 31, 2018 | 0.67 |
| Dec 31, 2017 | 0.66 |
| Sep 30, 2017 | 0.71 |
| Jun 30, 2017 | 0.80 |
| Mar 31, 2017 | 0.76 |
| Dec 31, 2016 | 0.69 |
| Sep 30, 2016 | 0.69 |
| Jun 30, 2016 | 0.75 |
| Mar 31, 2016 | 0.81 |
| Dec 31, 2015 | 0.78 |
| Sep 30, 2015 | 0.68 |
| Jun 30, 2015 | 0.72 |
| Mar 31, 2015 | 0.70 |
| Dec 31, 2014 | 0.65 |
| Sep 30, 2014 | 0.66 |
| Jun 30, 2014 | 0.55 |
| Mar 31, 2014 | 0.58 |
| Dec 31, 2013 | 0.72 |
| Sep 30, 2013 | 1.07 |
| Jun 30, 2013 | 1.04 |
| Mar 31, 2013 | 1.00 |
| Dec 31, 2012 | 0.95 |
| Sep 30, 2012 | 0.70 |
| Jun 30, 2012 | 0.56 |
| Mar 31, 2012 | 0.32 |
| Dec 31, 2011 | 0.27 |
| Sep 30, 2011 | 0.38 |
| Jun 30, 2011 | 0.35 |
| Mar 31, 2011 | 0.39 |